BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36282074)

  • 1. Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study.
    Bager JE; Martín A; Carbajosa Dalmau J; Simon A; Merino JL; Ritz B; Hartikainen JEK
    Cardiology; 2022; 147(5-6):566-577. PubMed ID: 36282074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vernakalant hydrochloride: A novel atrial-selective agent for the cardioversion of recent-onset atrial fibrillation in the emergency department.
    Stiell IG; Dickinson G; Butterfield NN; Clement CM; Perry JJ; Vaillancourt C; Calder LA
    Acad Emerg Med; 2010 Nov; 17(11):1175-82. PubMed ID: 21175515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
    Lévy S; Hartikainen J; Ritz B; Juhlin T; Carbajosa-Dalmau J; Domanovits H
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):283-292. PubMed ID: 33206300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge.
    Stoneman P; Gilligan P; Mahon P; Sheahan R
    Ir J Med Sci; 2017 Nov; 186(4):903-908. PubMed ID: 28168639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
    Savelieva I; Graydon R; Camm AJ
    Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety Profiles of Vernakalant for Cardioversion of Acute-onset Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Yu C; Li J; Zhao C; Guan Y; Wu D; Sun B; Wang X
    Clin Ther; 2023 Mar; 45(3):218-231. PubMed ID: 36828756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter.
    Stiell IG; Clement CM; Perry JJ; Vaillancourt C; Symington C; Dickinson G; Birnie D; Green MS
    CJEM; 2010 May; 12(3):181-91. PubMed ID: 20522282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation.
    Ma W; Guo X; Wang Q; Sun G; Wang J
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):32-41. PubMed ID: 32251022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.
    Mochalina N; Juhlin T; Öhlin B; Carlson J; Holmqvist F; Platonov PG
    Ann Noninvasive Electrocardiol; 2015 Mar; 20(2):140-7. PubMed ID: 25040826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis.
    Akel T; Lafferty J
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12508. PubMed ID: 29105209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
    Simon A; Niederdoeckl J; Skyllouriotis E; Schuetz N; Herkner H; Weiser C; Laggner AN; Domanovits H; Spiel AO
    Europace; 2017 Feb; 19(2):233-240. PubMed ID: 28175295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
    Camm AJ; Capucci A; Hohnloser SH; Torp-Pedersen C; Van Gelder IC; Mangal B; Beatch G;
    J Am Coll Cardiol; 2011 Jan; 57(3):313-21. PubMed ID: 21232669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Intravenous Vernakalant in Rapid Cardioversion of Recent Onset Atrial Fibrillation: A Retrospective Single-Centre Study.
    Hoteit A; Moumneh MB; Nahlawi A; Hebbo E; Abdulhai F; Abi-Saleh B; Khoury M; Refaat M
    Cureus; 2024 Apr; 16(4):e58616. PubMed ID: 38770450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
    Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
    Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.
    Beatch GN; Bhirangi K; Juul-Moller S; Rustige J
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):86-92. PubMed ID: 27828791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y; Dobrev D
    Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM; Roy D; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Retyk E; Drenning DH;
    Am J Cardiol; 2010 Nov; 106(9):1277-83. PubMed ID: 21029824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
    Farkowski MM; Maciag A; Zurawska M; Kowalik I; Szwed H; Pytkowski M
    Cardiovasc Ther; 2018 Dec; 36(6):e12469. PubMed ID: 30281920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.